ARCHIVES

DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions

This article is from The Cancer Letter archive.

Vol. 06 No. 42 | October 24, 1980

Download PDF Visit The Full Archive

Related Articles

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

Clinical Instigator Object To HEW Proposal On Compensation Notification In Consent Forms

December 15, 1978

Coalitions Diverge On NIH Role, Agree On Need For More Basic Research

February 19, 1993

An Unusual Week Of Deals In Oncology: Alliances, Sales, and Dramatic Moves

November 13, 1998

Columbia Next for comprehensive Center Review

February 18, 1977

In Brief: Biomedical Panel Report Will Support Cancer Program, Targeted Research

January 16, 1976